ANCHOR presentation at ASH 2020
December 6, 2020
Oncopeptides presented new data from phase 2 ANCHOR combination study in multiple myeloma the 62nd American Society of Hematology virtual annual meeting ASH, December 6, 2020.
See presentation below.
Menu
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
Austria
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Austrian operations at oncopeptides.at -
Italy
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Italian operations at oncopeptides.it
Change Language
-
-
ONCO5.28 SEK0%0 SEK
-
-
Change Region
-
Global
-
Germany
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our German operations at oncopeptides.de
-
Spain
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Spanish operations at oncopeptides.es
-
Austria
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Austrian operations at oncopeptides.at -
Italy
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you the website of our Italian operations at oncopeptides.it
Change Language
-
-
ONCO5.28 SEK0%0 SEK
-